![Terbutalin-Markt wird bis 2030 Umsatzsteigerungen verzeichnen | AstraZeneca, Hikma Pharmaceuticals, Bedford Pharmaceuticals – EKZ CrossTour Terbutalin-Markt wird bis 2030 Umsatzsteigerungen verzeichnen | AstraZeneca, Hikma Pharmaceuticals, Bedford Pharmaceuticals – EKZ CrossTour](https://ekz-crosstour.ch/wp-content/uploads/2023/10/4-1.jpg)
Terbutalin-Markt wird bis 2030 Umsatzsteigerungen verzeichnen | AstraZeneca, Hikma Pharmaceuticals, Bedford Pharmaceuticals – EKZ CrossTour
![DE602005000675T2 - Pharmaceutical polymer formulation for sustained release of terbutaline sulfate - Google Patents DE602005000675T2 - Pharmaceutical polymer formulation for sustained release of terbutaline sulfate - Google Patents](https://patentimages.storage.googleapis.com/4c/de/60/d11c855490112e/00210002.png)
DE602005000675T2 - Pharmaceutical polymer formulation for sustained release of terbutaline sulfate - Google Patents
![DE602005000675T2 - Pharmaceutical polymer formulation for sustained release of terbutaline sulfate - Google Patents DE602005000675T2 - Pharmaceutical polymer formulation for sustained release of terbutaline sulfate - Google Patents](https://patentimages.storage.googleapis.com/fe/b9/d0/f243706b4c280b/00340001.png)